Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers

Abstract The biocompatibility and immunocompatibility of polymeric materials is of fundamental importance for their possible therapeutic uses. Aspects of biocompatibility of solid polymeric materials and soluble polymeric materials differ. Solid materials are used in polymer implants, as membranes in kidney dialysis and cardiopulmonary bypass, for polymer coating of other materials to increase their biocompatibility, for encapsulation of cells producing hormones and other soluble factors, or as microspheres used for antigen or drug release. Soluble polymeric materials are mostly used as carriers of drugs, hormones, growth factors, enzymes and other active substances. Bio-and immunocompatibility comprises a complex response which depends both on the physico-chemical characteristics of the medical material and on the hereditary and acquired ability of the recipient to react.

[1]  C. Dinarello,et al.  C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha , 1988, The Journal of experimental medicine.

[2]  S. Stevenson,et al.  Evaluation of biocompatible osteoconductive polymer as an orthopedic implant in dogs. , 1992, Journal of the American Veterinary Medical Association.

[3]  N V Katre,et al.  Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. , 1990, Journal of immunology.

[4]  A. Pennings,et al.  Porous polymer implant for repair of meniscal lesions: a preliminary study in dogs. , 1991, Biomaterials.

[5]  J. Scales,et al.  Incidence of metal sensitivity in patients with total joint replacements. , 1975, British medical journal.

[6]  A. Dalmasso,et al.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. , 1977, The Journal of clinical investigation.

[7]  P. Doty,et al.  STUDIES ON SYNTHETIC POLYPEPTIDE ANTIGENS. XI. THE ANTIGENICITY OF OPTICALLY ISOMERIC SYNTHETIC POLYPEPTIDES. , 1964, The Journal of biological chemistry.

[8]  R. Niven,et al.  Pulmonary absorption of polyethylene glycolated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) , 1994 .

[9]  C. Sledge,et al.  Biochemical and histological evaluation of the synovial-like tissue around failed (loose) total joint replacement prostheses in human subjects and a canine model. , 1990, Biomaterials.

[10]  D. Rahman,et al.  Biodegradable microparticles as controlled release antigen delivery systems. , 1991, Immunology.

[11]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[12]  F. Balkwill,et al.  The cytokine network. , 1989, Immunology today.

[13]  W. Park,et al.  Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. , 1995, Biomaterials.

[14]  E. Macewen,et al.  Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma. , 1992, Journal of veterinary internal medicine.

[15]  G. Ciapetti,et al.  Production of prostacyclin and fibrinolysis modulators by endothelial cells cultured in the presence of polyethylene terephthalate. , 1993, Journal of biomedical materials research.

[16]  T. Balstad,et al.  Generation and removal of anaphylatoxins during hemofiltration with five different membranes. , 1988, Blood purification.

[17]  A. Jayakrishnan,et al.  Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. , 1996, Biomaterials.

[18]  K. Bendtzen,et al.  Autoantibodies to cytokines--friends or foes? , 1990, Immunology today.

[19]  Brown Jm Polyurethane and silicone: myths and misconceptions. , 1995 .

[20]  Y. Tsutsumi,et al.  Chemical Modification of Natural Human Tumor Necrosis Factor‐α with Polyethylene Glycol Increases Its Anti‐tumor Potency , 1994, Japanese journal of cancer research : Gann.

[21]  A. Swanson,et al.  Long-term silicone implant arthroplasty. Implications of animal and human autopsy findings. , 1983, JAMA.

[22]  D. Williams,et al.  Biocompatibility of tissue analogs , 1985 .

[23]  R. Goldblum,et al.  Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts , 1992, The Lancet.

[24]  J. Soothill,et al.  Time sequence of acute phase reactive proteins following surgical trauma. , 1966, Clinica chimica acta; international journal of clinical chemistry.

[25]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[26]  J. Kopecek,et al.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. , 1987, British Journal of Cancer.

[27]  K. Ulbrich,et al.  Effect of the chemical structure of N- (2- hydroxypropyl) methacrylajnide copolymers on their ability to induce antibody formation in inbred strains of mice , 1984 .

[28]  K. Tracey,et al.  Peptide Regulatory Factors CACHECTIN/TUMOUR NECROSIS FACTOR , 1989, The Lancet.

[29]  S. Davis,et al.  The immunogenicity of a model protein entrapped in poly(lactide-co-glycolide) microparticles prepared by a novel phase separation technique , 1994 .

[30]  J. Anderson,et al.  Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. , 1988, Journal of biomedical materials research.

[31]  F. Davis,et al.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.

[32]  S. Mizel,et al.  Interleukin 1, a potential regulator of fibroblast proliferation. , 1982, Journal of immunology.

[33]  T. Hirano,et al.  Molecular regulation of B lymphocyte response. , 1988, Annual review of immunology.

[34]  E. Kaplan,et al.  Silicone-Induced Human Adjuvant Disease? , 1983, Annals of plastic surgery.

[35]  A. Sehon Carl Prausnitz Memorial Lecture. Suppression of antibody responses by chemically modified antigens. , 1991, International archives of allergy and applied immunology.

[36]  Y. Tsutsumi,et al.  Polyethylene glycol modification of interleukin-6 enhances its thrombopoietic activity , 1995 .

[37]  V. Šubr,et al.  Immunogenicity of Protein-N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates in A/J and B10 Mice , 1990 .

[38]  T. Watanabe,et al.  Fever and acute phase response induced in rabbits by human recombinant interferon‐gamma. , 1987, The Journal of physiology.

[39]  T. Matsuda,et al.  Novel photoreactive surface modification technology for fabricated devices. , 1990, ASAIO transactions.

[40]  K. Ulbrich,et al.  Biocompatibility of Biopolymers , 1992 .

[41]  J. M. Harris,et al.  Poly(Ethylene Glycol) Chemistry , 1992 .

[42]  I. Feuerstein,et al.  Adherent platelet morphology on adsorbed fibrinogen: effects of protein incubation time and albumin addition. , 1994, Journal of biomedical materials research.

[43]  B. Říhová,et al.  Immunological problems of polymer-bound drugs. , 1985, Critical reviews in therapeutic drug carrier systems.

[44]  H. Maeda,et al.  Toxicity of Bilirubin and Detoxification by PEG-Bilirubin Oxidase Conjugate , 1992 .

[45]  R. Smith,et al.  Silicone synovitis of the wrist. , 1985, The Journal of hand surgery.

[46]  M. Alonso,et al.  Novel Approaches to Controlled-Release Antigen Delivery , 1994, International Journal of Technology Assessment in Health Care.

[47]  E. Ruckenstein,et al.  Preparation and characterization of thin film surface coatings for biological environments. , 1986, Biomaterials.

[48]  C. A. van Blitterswijk,et al.  In vitro biocompatibility testing of polylactides Part I Proliferation of different cell types , 1992 .

[49]  R Weissleder,et al.  A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.

[50]  K. Matsushima,et al.  There is more than one interleukin 1. , 1986, Immunology today.

[51]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[52]  F. Schué,et al.  Modification of the biocompatible and haemocompatible properties of polymer substrates by plasma-deposited fluorocarbon coatings. , 1992, Biomaterials.

[53]  I. Yada,et al.  Hematological problems during the use of cardiac assist devices: clinical experiences in Japan. , 2008, Artificial organs.

[54]  M. Hashida,et al.  In vitro cytotoxicity of macromolecules in different cell culture systems , 1995 .

[55]  P. Malchesky,et al.  Evaluation of a relationship between polymer bulk hydroxyl and surface oxygen content and in vitro serum-material interaction. , 1993, Journal of biomedical materials research.

[56]  M. Barbosa,et al.  Differential effects of eight metal ions on lymphocyte differentiation antigens in vitro. , 1990, Journal of biomedical materials research.

[57]  K. P. Rao,et al.  In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels. , 1990, Biomaterials.

[58]  T. Shimoyama,et al.  In Vitro Evaluation of a Relationship Between Human Serumor Plasma-Material Interaction and Polymer Bulk Hydroxyl and Surface Oxygen Content , 1993, ASAIO journal.

[59]  R. Stroud,et al.  Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. , 1976, Immunochemistry.

[60]  W. Hörl,et al.  Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. , 1986, Clinical nephrology.

[61]  V. Vetvicka,et al.  Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. , 1988, Clinical immunology and immunopathology.

[62]  E. Ritz,et al.  Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. , 1988, Kidney international.

[63]  B. Descamps-Latscha,et al.  Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. , 1985, Kidney international.

[64]  B. Beutler,et al.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.

[65]  B. Říhová,et al.  Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugates☆ , 1985 .

[66]  J. Hubbell,et al.  The short-term blood biocompatibility of poly(hydroxyethyl methacrylate-co-methyl methacrylate) in an in vitro flow system measured by digital videomicroscopy. , 1989, Journal of biomaterials science. Polymer edition.

[67]  L. Chess,et al.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.

[68]  S. Jimenez,et al.  Systemic sclerosis after augmentation mammoplasty with silicone implants. , 1989, Annals of internal medicine.

[69]  C. Doyle Advances in biomaterials: Lee SM editor 1987 Volume 1. Lancaster, PA: Technomics Inc. 286pp. $65 , 1987 .

[70]  J. Kopeček Synthesis of Tailor-Made Soluble Polymeric Drug Carriers , 1984 .

[71]  D. Roccatello,et al.  Serum and intracellular detection of cytokines in patients undergoing chronic hemodialysis. , 2008, Artificial organs.

[72]  J. Kopeček,et al.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. , 1988, British Journal of Cancer.

[73]  R. Pabst,et al.  Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? , 1990, Immunology today.

[74]  H. Colten,et al.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.

[75]  F. Ashley A NEW TYPE OF BREAST PROSTHESIS: Preliminary Report , 1970, Plastic and reconstructive surgery.

[76]  J. A. Hubbell,et al.  Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly(ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. , 1995, Biomaterials.

[77]  T. Kircher Silicone lymphadenopathy: a complication of silicone elastomer finger joint prostheses. , 1980, Human pathology.

[78]  W. Laird,et al.  Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[79]  F. Ashley FURTHER STUDIES ON THE NATURAL‐Y BREAST PROSTHESIS , 1972, Plastic and Reconstructive Surgery.

[80]  O. Reikerås,et al.  Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. , 1992, The European journal of surgery = Acta chirurgica.

[81]  T. Lint,et al.  Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations. , 1975, Journal of immunology.

[82]  A. Pizzoferrato,et al.  Numerical and functional modifications in platelets induced by polyester coated by a hydrophilic polymer. , 1993, Biomaterials.

[83]  S. Fukushima,et al.  Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacyl-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. , 1992, Journal of pharmaceutical sciences.

[84]  I. Pastan,et al.  Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin. , 1993, Cancer research.

[85]  R. Gurny,et al.  Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil. , 1994, Journal of biomedical materials research.

[86]  W. van Oeveren,et al.  Platelet Function Analysis After In Vitro Treatment with Hemostasis-Affecting Components , 1995, Seminars in Thrombosis & Hemostasis.

[87]  N. L. Krinick,et al.  Targetable photoactivalable drugs. 3. In vitro efficacy of polymer bound chlorin e6 toward human hepatocarcinoma cell line (PLC/PRF/5) targeted with galactosamine and to mouse splenocytes targeted with anti-Thy 1.2 antibodies , 1993 .

[88]  C. Price,et al.  Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein. , 1987, Journal of immunological methods.

[89]  L. Henderson,et al.  Biocompatibility of artificial organs: an overview. , 1987, Blood purification.

[90]  K. James Interactions between cytokines and α2-macroglobulin , 1990 .

[91]  I. Colombo,et al.  Investigation of surface properties of some polymers by a thermodynamic and mechanical approach: possibility of predicting mucoadhesion and biocompatibility. , 1994, Biomaterials.

[92]  M. Nucci,et al.  The therapeutic value of poly(ethylene glycol)-modified proteins , 1991 .

[93]  L. Henderson,et al.  Complement activation during hemodialysis: laboratory evaluation of hemodialyzers. , 1987, Artificial organs.

[94]  Hashida Mitsuru,et al.  Pharmacokinetics of succinylated proteins and dextran sulfate in mice : implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors , 1994 .

[95]  R. Faith,et al.  Effects of stress on the immune system. , 1990, Immunology today.

[96]  J. Kopeček,et al.  Soluble synthetic polymers as potential drug carriers , 1984 .

[97]  H De Geest,et al.  Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. , 1995, Atherosclerosis.

[98]  Y. Inada,et al.  Review : Polyethylene Glycol(PEG)-Protein Conjugates: Application to Biomedical and Biotechnological Processes , 1990 .

[99]  D. Louria,et al.  THE EFFECTS OF CORTISONE ON EXPERIMENTAL FUNGUS INFECTIONS * , 1960, Annals of the New York Academy of Sciences.

[100]  B. Stadler,et al.  Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). , 1981, Journal of immunology.

[101]  D. Williams,et al.  Immune response in biocompatibility. , 1992, Biomaterials.

[102]  R. Tamargo,et al.  Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. , 1989, Selective cancer therapeutics.

[103]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[104]  S. Akira,et al.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[105]  J. Remon,et al.  Immunogenicity of poly-D-lysine, a potential polymeric drug carrier , 1994 .

[106]  P. Bullough,et al.  Synovial and osseous inflammation in failed silicone-rubber prostheses. , 1982, The Journal of bone and joint surgery. American volume.

[107]  C. Peimer,et al.  Reactive synovitis after silicone arthroplasty. , 1986, The Journal of hand surgery.

[108]  A. Sehon Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens. , 1982, Progress in allergy.

[109]  K. Tracey,et al.  Cachectin/tumour necrosis factor. , 1989, Lancet.

[110]  F. Wiese,et al.  Chemical modification of cellulosic membranes and their blood compatibility. , 2008, Artificial organs.

[111]  A. Abuchowski,et al.  The clinical efficacy of poly(ethylene glycol)-modified proteins , 1990 .

[112]  H. Northoff,et al.  Discrimination of hepatocyte‐stimulating activity from human recombinant tumor necrosis factor α , 1987, European journal of immunology.

[113]  M. Robson,et al.  Experimental demonstration of the immunogenicity of silicone-protein complexes. , 1987, Journal of biomedical materials research.

[114]  G. Weissmann,et al.  Tumor necrosis factor provokes superoxide anion generation from neutrophils. , 1986, Biochemical and biophysical research communications.

[115]  M. Hershfield,et al.  Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[116]  Larry V. McIntire,et al.  Leucocyte adhesion under flow conditions: principles important in tissue engineering. , 1996, Biomaterials.

[117]  B. Říhová,et al.  The Activity of Complement in the Presence of N-(2-hydroxypropyl)methacrylamide Copolymers , 1986 .

[118]  D. J. Harrison,et al.  Preliminary in vivo biocompatibility studies on perfluorosulphonic acid polymer membranes for biosensor applications. , 1991, Biomaterials.

[119]  A. Irvine,et al.  Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity. , 1992, Experimental hematology.

[120]  B. Gander,et al.  A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. , 1995, Vaccine.

[121]  J. Anderson,et al.  Human monocyte/macrophage adhesion and cytokine production on surface-modified poly(tetrafluoroethylene/hexafluoropropylene) polymers with and without protein preadsorption. , 1995, Journal of biomedical materials research.

[122]  C. V. van Blitterswijk,et al.  Interfacial behavior of PEO/PBT copolymers (Polyactive) in a calvarial system: an in vitro study. , 1994, Journal of biomedical materials research.

[123]  R. Tompkins,et al.  Long‐Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration , 1991, Biotechnology progress.

[124]  J. Kopeček,et al.  Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. , 1987, Journal of biomedical materials research.

[125]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[126]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[127]  J. Moragas,et al.  Lymphocyte transformation test in allergic contact nickel dermatitis , 1975, The British journal of dermatology.

[128]  D. Springfield,et al.  Pseudotumor of the arm associated with rupture of silicone-gel breast prostheses. Report of two cases. , 1983, The Journal of bone and joint surgery. American volume.

[129]  S. Akira,et al.  Biological and clinical aspects of interleukin 6. , 1990, Immunology today.

[130]  A. Koj,et al.  The Acute-phase response to injury and infection : the roles of interleukin 1 and other mediators , 1985 .

[131]  J. Oleffe,et al.  Methylmethacrylate hypersensitivity in a patient with cemented endoprosthesis. A case report. , 1978, Acta orthopaedica Scandinavica.

[132]  W. Goebel,et al.  Reactions to acrylic resin dental prostheses. , 1980, The Journal of prosthetic dentistry.

[133]  E. Balazs,et al.  Hylan gel biomaterial: dermal and immunologic compatibility. , 1993, Journal of biomedical materials research.

[134]  T. Luger,et al.  Blood-membrane interaction in hemodialysis leads to increased cytokine production. , 1987, Kidney international.

[135]  W. Shen,et al.  Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[136]  R. Nakamura,et al.  Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications. , 1976, American journal of clinical pathology.

[137]  K. Ulbrich,et al.  Antibody-targeted cyclosporin A , 1992 .

[138]  R. Langer,et al.  Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. , 1990, Journal of biomedical materials research.

[139]  R. Duncan,et al.  Biological Evaluation of Soluble Synthetic Polymers as Drug Carriers , 1984 .

[140]  R. Gurny,et al.  Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery system. , 1989, Journal of biomedical materials research.

[141]  R. Ward,et al.  Response of complement and neutrophils to hydrophilized synthetic membranes. , 1988, ASAIO transactions.

[142]  D. Stern,et al.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.

[143]  R. Ross,et al.  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. , 1976, The American journal of pathology.

[144]  M. Kazatchkine,et al.  The role of naturally-occurring antibodies against man-made materials in biocompatibility , 1990 .

[145]  K. Ulbrich,et al.  Immunogenicity of N‐(2‐hydroxypropyl) methacrylamide copolymers , 1985 .

[146]  L. Pulliam,et al.  Multiple biological activities of a partially purified leukocytic endogenous mediator. , 1973, The American journal of physiology.

[147]  D. Falkenhagen,et al.  Biocompatibility--a system approach. , 1989, Advances in experimental medicine and biology.

[148]  M. Loos,et al.  Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4. , 1976, Immunochemistry.

[149]  Low Friction Hydrophilic Surface for Medical Devices , 1990 .

[150]  T. Matsuda,et al.  Surface coating of hydrophilic-hydrophobic block co-polymers on a poly(acrylonitrile) haemodialyser reduces platelet adhesion and its transmembrane stimulation. , 1994, Biomaterials.

[151]  I. Kushner THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.

[152]  J. Anderson,et al.  Biomaterial biocompatibility and the macrophage. , 1984, Biomaterials.

[153]  F. H. van der Veen,et al.  Studies on a new radiopaque polymeric biomaterial. , 1994, Biomaterials.

[154]  K. Ulbrich,et al.  Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. , 1989, Biomaterials.

[155]  J. Gauldie,et al.  Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. , 1990, Molecular biology & medicine.

[156]  K. Ulbrich,et al.  Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycin , 1989 .

[157]  M. Doni,et al.  METHYLMETHACRYLATE HYPERSENSITIVITY IN A PATIENT WITH CEMENTED ENDOPROSTHESIS , 1978 .

[158]  N Kossovsky,et al.  Biocompatibility of Silicone Implants , 1983, Annals of plastic surgery.

[159]  D. Fearon,et al.  Biocompatibility of dialysis membranes: effects of chronic complement activation. , 1984, Kidney international.

[160]  J. Bauer,et al.  Regulation of interleukin‐6 receptor expression in human monocytes and hepatocytes , 1989, FEBS letters.

[161]  J. Vacík,et al.  Experimental implantation of hydrogel into the bone. , 1988, Journal of biomedical materials research.

[162]  J. Vienken,et al.  Considerations on developmental aspects of biocompatible dialysis membranes. , 1995, Artificial organs.

[163]  J. Anderson,et al.  A hydrophilic plasma polymerized film composite with potential application as an interface for biomaterials. , 1990, Journal of biomedical materials research.

[164]  A. Lanzavecchia,et al.  Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. , 1985, Journal of immunology.

[165]  P. Christel,et al.  Plasma protein adsorption to artificial ligament fibers. , 1995, Journal of biomedical materials research.

[166]  J. Uhr,et al.  Immunotoxins: magic bullets or misguided missiles? , 1993, Trends in pharmacological sciences.

[167]  N L Burnham,et al.  Polymers for delivering peptides and proteins. , 1994, American journal of hospital pharmacy.

[168]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[169]  J. B. Liesch,et al.  Differential production of interleukin 1 on the surface of biomaterials. , 1990, Archives of surgery.

[170]  D. Magilligan,et al.  Fate of a second porcine bioprosthetic valve. , 1983, The Journal of thoracic and cardiovascular surgery.